Carl Kay, MD(@CarlKayMD) 's Twitter Profile Photo

Pouch Review from Laura Raffals, MD at

▪️Pouch anatomy (J, S, W, K)
▪️Endoscopic landmarks of J
▪️Pouch complications DDx
▪️Treatment algorithm for pouchitis

Pouch Review from @LauraRaffalsMD at #ACG2019

▪️Pouch anatomy (J, S, W, K)
▪️Endoscopic landmarks of J
▪️Pouch complications DDx
▪️Treatment algorithm for pouchitis

#GITwitter #IBD
account_circle
Malcolm Tan(@IBDGastroDocSg) 's Twitter Profile Photo

J-pouch anatomy:
- appreciating the anatomy & accurate endoscopic reporting is critical in understanding the aetiology of 'pouchitis'
- different segmental involvement suggest different causes --> different rx approaches

J-pouch anatomy: 
- appreciating the anatomy & accurate endoscopic reporting is critical in understanding the aetiology of 'pouchitis'
- different segmental involvement suggest different causes --> different rx approaches
account_circle
IBD Horizons(@IBDHorizons) 's Twitter Profile Photo

Horizons24

Research in :
VDZ works well for pouchitis
UPA for
Risa for
Combo is the way to go, no monotherapy for UC
IL23’s likely more effective than the others

#IBDHorizons24 #BrianFeagan

Research in #IBD:
VDZ works well for pouchitis
UPA for #UlcerativeColitis
Risa for #Crohns
Combo is the way to go, no monotherapy for UC
IL23’s likely more effective than the others
account_circle
Malcolm Tan(@IBDGastroDocSg) 's Twitter Profile Photo

Pouch disorders are challenging to manage:

- antibiotics still the mainstay rx for acute/chronic pouchitis
- budesonide or topical steroids
- anti-TNF, vedolizumab for chronic antibiotic-refractory pouchitis or Crohn's-like disease of the pouch

doi: 10.1038/s41575-024-00920-5

Pouch disorders are challenging to manage:

- antibiotics still the mainstay rx for acute/chronic pouchitis
- budesonide or topical steroids 
- anti-TNF, vedolizumab for chronic antibiotic-refractory pouchitis or Crohn's-like disease of the pouch

doi: 10.1038/s41575-024-00920-5
account_circle
John Damianos, M.D.(@john_damianosMD) 's Twitter Profile Photo

Fecal microbiota transplantation is no better than placebo for chronic pouchitis, and had ⬆️ adverse events.



academic.oup.com/ecco-jcc/advan…

Fecal microbiota transplantation is no better than placebo for chronic pouchitis, and had ⬆️ adverse events. 

#MedTwitter #GITwitter #IBD #FMT #microbiome 

academic.oup.com/ecco-jcc/advan…
account_circle
Emory Gastroenterology and Hepatology Fellowship(@EmoryGastroHep) 's Twitter Profile Photo

📷Faculty Retroflexions📷

🚨High yield! Dr. David Eskreis gives us insight regarding the AGA Guidelines on the Management of Pouchitis and Inflammatory Pouch Disorders. Please see our fellow’s (Andres Rodriguez, DO, MBA) associated visual abstract!

📷Faculty Retroflexions📷

🚨High yield! Dr. David Eskreis gives us insight regarding the AGA Guidelines on the Management of Pouchitis and Inflammatory Pouch Disorders. Please see our fellow’s (@ARodriguezDO) associated visual abstract! 
#FacultyRetroflexions #EmoroidDigest
account_circle
Laura Tar 🏳️‍⚧️👩🏼‍⚕️(@laura_tee_mdgi) 's Twitter Profile Photo

****ANNOUNCING***

GI Paper Breakdown #9

nejm.org/doi/full/10.10…

⭐️⭐️ Is VDZ EFFECTIVE FOR TREATMENT OF CHRONIC POUCHITIS ⭐️⭐️

➡️➡️ Does it improve symptoms???
➡️➡️ Does it improve endoscopic appearance??
➡️➡️ Does it improve quality of life???

Full Review Coming Today!!!

****ANNOUNCING***

GI Paper Breakdown #9 

nejm.org/doi/full/10.10…

⭐️⭐️ Is VDZ EFFECTIVE FOR TREATMENT OF CHRONIC POUCHITIS ⭐️⭐️

➡️➡️ Does it improve symptoms???
➡️➡️ Does it improve endoscopic appearance??
➡️➡️ Does it improve quality of life???

Full Review Coming  Today!!!
account_circle
Robert Dudkowiak MD, PhD(@drRobinDud) 's Twitter Profile Photo

Medical & dietetic management of the ileal pouch durig D-ECCO
workshops 🤩

Amazing lessons with amazing 🌟🌟from 🇮🇱 iris dotan & Lihi Godny 🫶🏻👌🏿🫶🏽

🥗
🦠
🔃
💊
🔥
and 😬

🇸🇪

Medical & dietetic management of the ileal pouch durig @D_ECCO_IBD
workshops 🤩

Amazing lessons with amazing 🌟🌟from 🇮🇱 @Iris_Dotan & @LGodny 🫶🏻👌🏿🫶🏽

#diet 🥗 
#microbiome🦠
#dysbiosis 🔃
#antibootics 💊 
#inflamation 🔥 
and #pouchitis 😬

#ECCO2024 🇸🇪
account_circle
Michael Chiorean(@mchiorean4) 's Twitter Profile Photo

Khoo - open label induction trial of TOFA in pts w chronic pouchitis (1/3 bio-IR) showing effectiveness in about 2/3 of patients after 8-16 weeks for both clinical & endoscopic endpoints. Maintenence withdrawal trial underway

Khoo - open label induction trial of TOFA in pts w chronic pouchitis (1/3 bio-IR) showing effectiveness in about 2/3 of patients after 8-16 weeks for both clinical & endoscopic endpoints. Maintenence withdrawal trial underway #DDW2024 #IBD
account_circle
Laura Tar 🏳️‍⚧️👩🏼‍⚕️(@laura_tee_mdgi) 's Twitter Profile Photo

So What Is the Importance of the EARNEST Study?

Should we be more confident in prescribing Vedolizumab for patients with chronic antibiotic dependent and refractory pouchitis?

The Upshot: Not all high-quality evidence is of equally high quality....

Let's see why.....

So What Is the Importance of the EARNEST Study?

Should we be more confident in prescribing Vedolizumab for patients with chronic antibiotic dependent and refractory pouchitis?

The Upshot: Not all high-quality evidence is of equally high quality....

Let's see why.....
account_circle
John Damianos, M.D.(@john_damianosMD) 's Twitter Profile Photo

The De Simone formulation may not be cost effective for the primary prevention of pouchitis, but is cost effective for the prevention of recurrent pouchitis.

s

The De Simone formulation #probiotic may not be cost effective for the primary prevention of pouchitis, but is cost effective for the prevention of recurrent pouchitis. 

#MedTwitter #GITwitter #IBD #probiotics #DDW2024
account_circle
Mount Sinai Division of Gastroenterology(@MountSinaiGI) 's Twitter Profile Photo

At this morning’s session about key challenges in , moderated by Dr. Marla Dubinsky, Maia Kayal MD addressed a full house, reminding all to seek balance in striving for complete remission with recognizing the value of incremental progress in the management of .

At this morning’s #DDW session about key challenges in #IBD, moderated by Dr. Marla Dubinsky, @MaiaKayalMD addressed a full house, reminding all to seek balance in striving for complete remission with recognizing the value of incremental progress in the management of #pouchitis.
account_circle
IBD Horizons(@IBDHorizons) 's Twitter Profile Photo



Dr brings us what’s come about in the studies that took place in 2022/23

💉VDZ treating pouchitis
💊Upa for
💉Risa approval
💊Combo return of golmumab/guselkumab
💉TL1A monoclonal for fibrostenosing

#IBDHorizons23 

Dr #BrianFeagan brings us what’s come about in the studies that took place in 2022/23

💉VDZ treating pouchitis
💊Upa for #UlcerativeColitis
💉Risa approval
💊Combo return of golmumab/guselkumab
💉TL1A monoclonal for fibrostenosing #Crohns
account_circle